SELLAS Life Sciences Group (SLS) Payables: 2011-2023
Historic Payables for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2023 value amounting to $5.6 million.
- SELLAS Life Sciences Group's Payables rose 4.77% to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $23.9 million, marking a year-over-year increase of 64.65%. This contributed to the annual value of $5.6 million for FY2023, which is 67.98% up from last year.
- According to the latest figures from FY2023, SELLAS Life Sciences Group's Payables is $5.6 million, which was up 67.98% from $3.4 million recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's Payables registered a high of $5.6 million during FY2023, and its lowest value of $2.1 million during FY2021.
- Its 3-year average for Payables is $3.7 million, with a median of $3.4 million in 2022.
- In the last 5 years, SELLAS Life Sciences Group's Payables plummeted by 53.96% in 2021 and then skyrocketed by 67.98% in 2023.
- Yearly analysis of 5 years shows SELLAS Life Sciences Group's Payables stood at $3.9 million in 2019, then rose by 19.35% to $4.7 million in 2020, then plummeted by 53.96% to $2.1 million in 2021, then spiked by 56.58% to $3.4 million in 2022, then soared by 67.98% to $5.6 million in 2023.